<DOC>
	<DOCNO>NCT02831517</DOCNO>
	<brief_summary>The primary objective study : To evaluate pharmacokinetics ( PK ) property BIIB074 administer single oral dose healthy Japanese Caucasian participant ; To evaluate PK property BIIB074 administer repeated oral dos healthy Japanese participant . The secondary objective study assess safety tolerability BIIB074 administer single oral dose ( Japanese Caucasian participant ) repeat oral dos ( Japanese participant ) .</brief_summary>
	<brief_title>PK Safety Study BIIB074 Healthy Japanese Caucasian Participants</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Trigeminal Neuralgia</mesh_term>
	<criteria>Key Japanese Caucasian . Japanese participant must bear Japan , biological parent grandparent must Japanese origin . Must body mass index 18 30 kg/m2 , inclusive . Key Previous exposure BIIB074 , exception Japanese participant complete Part 1 . Use oral , injected , implanted hormonal method contraception contain ethinyl estradiol within 28 day Day 1 unwillingness refrain product use study participation . NOTE : Other protocol define Inclusion/Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>